Posts Tagged ‘Switzerland’
Nanolive raises US $ 20 million
The Swiss company is a pioneer in the development of live-cell imaging, and digital analytical solutions The swiss leading live-cell imaging and analysis company, announces that it has successfully completed the initial closing of US $20 million in the Series C-1 equity financing round of investment, led by a US-based and NASDAQ listed life science…
Read MoreA MEG plateform at Campus Biotech in 2022
A new device for brain research at the Campus Biotech Next summer, the Human Neuroscience Platform (HNP) at Campus Biotech will acquire and install a new Magnetoencephalography (MEG). The new MEGIN Triux neo will integrate the already existing MEEG-BCI MRI facility. Magnetoencephalography (MEG) is a non-invasive imaging technique for investigating human brain activity. Dr…
Read MoreCompletely locked-in man uses brain-computer interface to communicate
Researchers at the Wyss Center Geneva created a device and a computer program to decode brain signals Completely paralyzed and unable to speak, a 30-year-old man was able to speak with its caregivers and his family. He even managed to ask his 4-year-old son : “Do you want to watch Disney’s Robin Hood with…
Read MoreINTERVIEW – Ana Pinto
🔺 Why Western Switzerland🇨🇭 is so attractive to life sciences companies? Ana Pinto, Business Partner at the Service de l’Économie du Canton de Neuchâtel has the answer.
Read MoreNagi Bioscience won a € 2,5 million grant from the EIC Accelerator
The company revolutionizes pre-clinical testing with its pioneer Organism-on-Chip technology Nagi Bioscience has been bestowed the prestigious and highly selective EIC Accelerator Grant supporting breakthrough innovation in Europe, funded by the Swiss State Secretariat for Education, Research and Innovation (SERI) for Swiss Startups, for its pioneer Organism-on-Chip technology. The EPFL spin-off uses C. elegans, a small worm…
Read MoreMedical devices for Ukraine
The Ukraine Embassy launches an appeal for donations Collection points in Switzerland The war in Ukraine has thrown millions of people into exile and the health situation there is dramatic. There is a shortage of medical devices needed for basic care, transport and treatment of the wounded, and intensive care. In this context, the…
Read MoreSEED Biosciences raises CHF 400 000
The EPFL spin-off has developed a pipetting robot that can dispense individual cells one by one. The device, called Dispencell, saves precious time – up to several weeks – for life science researchers, and accelerates research in the fields of pharmaceuticals, cancer or personalized medicine. Today, finding the perfect cure for every cancer patient…
Read MoreA gene could prevent Parkinson’s disease
A mutation in the Fer2 gene causes motor deficiencies in flies The laboratory of Emi Nagoshi, Professor in the Department of Genetics and Evolution at the UNIGE Faculty of Science, uses the fruit fly, or Drosophila, to study the mechanisms of dopaminergic neuron degeneration. Her group is particularly interested in the Fer2gene, whose human…
Read MoreBioArk Monthey is expanding
A third building is under construction at BioArk Monthey Until now, BioArk has offered 6,000m2 of space between its first two buildings, BioArk I and II. BioArk III, with some 5,000m2 of floor space, including several 850m2 platforms, will house startups and companies active in the life sciences sector. The site offers unique multi-functional facilities,…
Read MoreCeidos revolutionises cell culture
The BioArk startup received a CHF 100 000 loan from FIT Advanced therapy medicinal products (ATMPs) are active medicines that are based on genes, tissues, or cells. They offer groundbreaking new opportunities for the treatment of cancers, degenerative diseases, genetic disorders, and injury. But producing them is a challenge and very expensive. Leonard Barras and…
Read More